Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Which Robo Advisor Is Best For Beginners compares onboarding ease, cost structures, and portfolio options to guide first-timers.
21,622 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Bank Of America upgrades TripAdvisor to Buy, signaling potential value from Viator and TheFork as Starboard Value exp...
The latest consumer sentiment 56.4 reading sets the tone for retail stocks and the VanEck Retail ETF (RTH) in 2026. I...
A Russian actor allegedly used forged ties to the Astor name to extract roughly $450 million from a Mexican billionai...
Bitcoin held near $80,000 as oil rose and the dollar strengthened, signaling a possible self-driven pull in BTC beyon...
Apple and Intel are reportedly exploring a U.S.-based chip supply and manufacturing pact. The talks, if they advance,...
After months of stubborn pricing, the market shows a negative turn in home values. This shift changes the playbook fo...
IonQ is moving from early-stage hardware to recurring cloud access and software tools. This article breaks down what ...
Apple’s measured AI approach contrasts with Microsoft’s aggressive spending, signaling a shift in investor bets as th...
The NEOS Gold High Income ETF has surged about 24% since its debut, yet investors should weigh the income wrapper tha...
When mortgage markets swung on interest-rate headlines, one fund pressed deeper into PennyMac. This article explains ...
Oil futures rose late Thursday as tensions in the Persian Gulf flared again, while stock-market futures were muted af...